Global Hydronephrosis Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 100 pages | ID: G6CC59BBB109EN
LP Information

Abstracts

According to this study, the global Hydronephrosis Treatment market size will reach US$ million by 2031.

Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Hydronephrosis Treatment Industry Forecast” looks at past sales and reviews total world Hydronephrosis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Hydronephrosis Treatment sales for 2025 through 2031. With Hydronephrosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydronephrosis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Hydronephrosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hydronephrosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hydronephrosis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydronephrosis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydronephrosis Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Hydronephrosis Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Surgical Treatment
• Drug Treatment

Segmentation by Application:

• Hospital
• Clinic
• Ambulatory Surgery Centre

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• NephroGenex
• PHRAXIS
• Allergan
• Amgen
• Anthem Group
• Sanofi
• Novartis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hydronephrosis Treatment Market Size (2020-2031)
  2.1.2 Hydronephrosis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Hydronephrosis Treatment by Country/Region (2020, 2024 & 2031)
2.2 Hydronephrosis Treatment Segment by Type
  2.2.1 Surgical Treatment
  2.2.2 Drug Treatment
2.3 Hydronephrosis Treatment Market Size by Type
  2.3.1 Hydronephrosis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Hydronephrosis Treatment Market Size Market Share by Type (2020-2025)
2.4 Hydronephrosis Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Ambulatory Surgery Centre
2.5 Hydronephrosis Treatment Market Size by Application
  2.5.1 Hydronephrosis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Hydronephrosis Treatment Market Size Market Share by Application (2020-2025)

3 HYDRONEPHROSIS TREATMENT MARKET SIZE BY PLAYER

3.1 Hydronephrosis Treatment Market Size Market Share by Player
  3.1.1 Global Hydronephrosis Treatment Revenue by Player (2020-2025)
  3.1.2 Global Hydronephrosis Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Hydronephrosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HYDRONEPHROSIS TREATMENT BY REGION

4.1 Hydronephrosis Treatment Market Size by Region (2020-2025)
4.2 Global Hydronephrosis Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hydronephrosis Treatment Market Size Growth (2020-2025)
4.4 APAC Hydronephrosis Treatment Market Size Growth (2020-2025)
4.5 Europe Hydronephrosis Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Hydronephrosis Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Hydronephrosis Treatment Market Size by Country (2020-2025)
5.2 Americas Hydronephrosis Treatment Market Size by Type (2020-2025)
5.3 Americas Hydronephrosis Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hydronephrosis Treatment Market Size by Region (2020-2025)
6.2 APAC Hydronephrosis Treatment Market Size by Type (2020-2025)
6.3 APAC Hydronephrosis Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hydronephrosis Treatment Market Size by Country (2020-2025)
7.2 Europe Hydronephrosis Treatment Market Size by Type (2020-2025)
7.3 Europe Hydronephrosis Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hydronephrosis Treatment by Region (2020-2025)
8.2 Middle East & Africa Hydronephrosis Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Hydronephrosis Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HYDRONEPHROSIS TREATMENT MARKET FORECAST

10.1 Global Hydronephrosis Treatment Forecast by Region (2026-2031)
  10.1.1 Global Hydronephrosis Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Hydronephrosis Treatment Forecast
  10.1.3 APAC Hydronephrosis Treatment Forecast
  10.1.4 Europe Hydronephrosis Treatment Forecast
  10.1.5 Middle East & Africa Hydronephrosis Treatment Forecast
10.2 Americas Hydronephrosis Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Hydronephrosis Treatment Forecast
  10.2.2 Canada Market Hydronephrosis Treatment Forecast
  10.2.3 Mexico Market Hydronephrosis Treatment Forecast
  10.2.4 Brazil Market Hydronephrosis Treatment Forecast
10.3 APAC Hydronephrosis Treatment Forecast by Region (2026-2031)
  10.3.1 China Hydronephrosis Treatment Market Forecast
  10.3.2 Japan Market Hydronephrosis Treatment Forecast
  10.3.3 Korea Market Hydronephrosis Treatment Forecast
  10.3.4 Southeast Asia Market Hydronephrosis Treatment Forecast
  10.3.5 India Market Hydronephrosis Treatment Forecast
  10.3.6 Australia Market Hydronephrosis Treatment Forecast
10.4 Europe Hydronephrosis Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Hydronephrosis Treatment Forecast
  10.4.2 France Market Hydronephrosis Treatment Forecast
  10.4.3 UK Market Hydronephrosis Treatment Forecast
  10.4.4 Italy Market Hydronephrosis Treatment Forecast
  10.4.5 Russia Market Hydronephrosis Treatment Forecast
10.5 Middle East & Africa Hydronephrosis Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Hydronephrosis Treatment Forecast
  10.5.2 South Africa Market Hydronephrosis Treatment Forecast
  10.5.3 Israel Market Hydronephrosis Treatment Forecast
  10.5.4 Turkey Market Hydronephrosis Treatment Forecast
10.6 Global Hydronephrosis Treatment Forecast by Type (2026-2031)
10.7 Global Hydronephrosis Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Hydronephrosis Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 NephroGenex
  11.1.1 NephroGenex Company Information
  11.1.2 NephroGenex Hydronephrosis Treatment Product Offered
  11.1.3 NephroGenex Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 NephroGenex Main Business Overview
  11.1.5 NephroGenex Latest Developments
11.2 PHRAXIS
  11.2.1 PHRAXIS Company Information
  11.2.2 PHRAXIS Hydronephrosis Treatment Product Offered
  11.2.3 PHRAXIS Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 PHRAXIS Main Business Overview
  11.2.5 PHRAXIS Latest Developments
11.3 Allergan
  11.3.1 Allergan Company Information
  11.3.2 Allergan Hydronephrosis Treatment Product Offered
  11.3.3 Allergan Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Allergan Main Business Overview
  11.3.5 Allergan Latest Developments
11.4 Amgen
  11.4.1 Amgen Company Information
  11.4.2 Amgen Hydronephrosis Treatment Product Offered
  11.4.3 Amgen Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Amgen Main Business Overview
  11.4.5 Amgen Latest Developments
11.5 Anthem Group
  11.5.1 Anthem Group Company Information
  11.5.2 Anthem Group Hydronephrosis Treatment Product Offered
  11.5.3 Anthem Group Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Anthem Group Main Business Overview
  11.5.5 Anthem Group Latest Developments
11.6 Sanofi
  11.6.1 Sanofi Company Information
  11.6.2 Sanofi Hydronephrosis Treatment Product Offered
  11.6.3 Sanofi Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Sanofi Main Business Overview
  11.6.5 Sanofi Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Hydronephrosis Treatment Product Offered
  11.7.3 Novartis Hydronephrosis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hydronephrosis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Hydronephrosis Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Surgical Treatment
Table 4. Major Players of Drug Treatment
Table 5. Hydronephrosis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Hydronephrosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Hydronephrosis Treatment Market Size Market Share by Type (2020-2025)
Table 8. Hydronephrosis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Hydronephrosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Hydronephrosis Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Hydronephrosis Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Hydronephrosis Treatment Revenue Market Share by Player (2020-2025)
Table 13. Hydronephrosis Treatment Key Players Head office and Products Offered
Table 14. Hydronephrosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hydronephrosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Hydronephrosis Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Hydronephrosis Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Hydronephrosis Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Hydronephrosis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Hydronephrosis Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Hydronephrosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Hydronephrosis Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Hydronephrosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Hydronephrosis Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Hydronephrosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Hydronephrosis Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Hydronephrosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Hydronephrosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Hydronephrosis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Hydronephrosis Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Hydronephrosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Hydronephrosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Hydronephrosis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Hydronephrosis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Hydronephrosis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hydronephrosis Treatment
Table 39. Key Market Challenges & Risks of Hydronephrosis Treatment
Table 40. Key Industry Trends of Hydronephrosis Treatment
Table 41. Global Hydronephrosis Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Hydronephrosis Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Hydronephrosis Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Hydronephrosis Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. NephroGenex Details, Company Type, Hydronephrosis Treatment Area Served and Its Competitors
Table 46. NephroGenex Hydronephrosis Treatment Product Offered
Table 47. NephroGenex Hydronephrosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. NephroGenex Main Business
Table 49. NephroGenex Latest Developments
Table 50. PHRAXIS Details, Company Type, Hydronephrosis Treatment Area Served and Its Competitors
Table 51. PHRAXIS Hydronephrosis Treatment Product Offered
Table 52. PHRAXIS Hydronephrosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. PHRAXIS Main Business
Table 54. PHRAXIS Latest Developments
Table 55. Allergan Details, Company Type, Hydronephrosis Treatment Area Served and Its Competitors
Table 56. Allergan Hydronephrosis Treatment Product Offered
Table 57. Allergan Hydronephrosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Allergan Main Business
Table 59. Allergan Latest Developments
Table 60. Amgen Details, Company Type, Hydronephrosis Treatment Area Served and Its Competitors
Table 61. Amgen Hydronephrosis Treatment Product Offered
Table 62. Amgen Hydronephrosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Amgen Main Business
Table 64. Amgen Latest Developments
Table 65. Anthem Group Details, Company Type, Hydronephrosis Treatment Area Served and Its Competitors
Table 66. Anthem Group Hydronephrosis Treatment Product Offered
Table 67. Anthem Group Hydronephrosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Anthem Group Main Business
Table 69. Anthem Group Latest Developments
Table 70. Sanofi Details, Company Type, Hydronephrosis Treatment Area Served and Its Competitors
Table 71. Sanofi Hydronephrosis Treatment Product Offered
Table 72. Sanofi Hydronephrosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Sanofi Main Business
Table 74. Sanofi Latest Developments
Table 75. Novartis Details, Company Type, Hydronephrosis Treatment Area Served and Its Competitors
Table 76. Novartis Hydronephrosis Treatment Product Offered
Table 77. Novartis Hydronephrosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Novartis Main Business
Table 79. Novartis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Hydronephrosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hydronephrosis Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Hydronephrosis Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Hydronephrosis Treatment Sales Market Share by Country/Region (2024)
Figure 8. Hydronephrosis Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Hydronephrosis Treatment Market Size Market Share by Type in 2024
Figure 10. Hydronephrosis Treatment in Hospital
Figure 11. Global Hydronephrosis Treatment Market: Hospital (2020-2025) & ($ millions)
Figure 12. Hydronephrosis Treatment in Clinic
Figure 13. Global Hydronephrosis Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Hydronephrosis Treatment in Ambulatory Surgery Centre
Figure 15. Global Hydronephrosis Treatment Market: Ambulatory Surgery Centre (2020-2025) & ($ millions)
Figure 16. Global Hydronephrosis Treatment Market Size Market Share by Application in 2024
Figure 17. Global Hydronephrosis Treatment Revenue Market Share by Player in 2024
Figure 18. Global Hydronephrosis Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Hydronephrosis Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Hydronephrosis Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Hydronephrosis Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Hydronephrosis Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Hydronephrosis Treatment Value Market Share by Country in 2024
Figure 24. United States Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Hydronephrosis Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Hydronephrosis Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Hydronephrosis Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Hydronephrosis Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Hydronephrosis Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Hydronephrosis Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Hydronephrosis Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Hydronephrosis Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Hydronephrosis Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Hydronephrosis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Hydronephrosis Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Hydronephrosis Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Hydronephrosis Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Hydronephrosis Treatment Market Size 2026-2031 ($ millions)